Skip to Main content Skip to Navigation
New interface
Journal articles

Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia

Claudie Bosc 1, 2 Estelle Saland 1, 3 Aurélie Bousard 4 Noémie Gadaud 1, 3, 5, 6 Marie Sabatier 1, 3 Guillaume Cognet 1, 3 Thomas Farge 1, 3 Emeline Boet 1, 3 Mathilde Gotanègre 7, 3 Nesrine Aroua 1, 3 Pierre-Luc Mouchel 1, 3, 5, 6 Nathaniel Polley 1, 3 Clément Larrue 1, 3 Eléonore Kaphan 1, 3 Muriel Picard 8 Ambrine Sahal 1, 3 Latifa Jarrou 1, 3 Marie Tosolini 1 Florian Rambow 4 Florence Cabon 1, 3 Nathalie Nicot 9 Laura Poillet-Perez 1, 3 Yujue Wang 10 Xiaoyang Su 10 Quentin Fovez 11 Jérôme Kluza 11 Rafael José Argüello 12 Céline Mazzotti 1, 13 Hervé Avet-Loiseau 1, 13 François Vergez 1, 3, 5, 6 Jérôme Tamburini 14 Jean-Jacques Fournié 1, 3 Ing Tiong 15 Andrew Wei 15 Tony Kaoma 9 Jean-Christophe Marine 4 Christian Récher 1, 3, 5, 6 Lucille Stuani 1 Carine Joffre 1, 3 Jean-Emmanuel Sarry 1, 3 
Document type :
Journal articles
Complete list of metadata

https://hal-amu.archives-ouvertes.fr/hal-03565962
Contributor : Anita DUMENIL Connect in order to contact the contributor
Submitted on : Friday, February 11, 2022 - 12:04:28 PM
Last modification on : Wednesday, November 23, 2022 - 12:02:30 PM

Identifiers

Citation

Claudie Bosc, Estelle Saland, Aurélie Bousard, Noémie Gadaud, Marie Sabatier, et al.. Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia. Nature Cancer, 2021, 2 (11), pp.1204-1223. ⟨10.1038/s43018-021-00264-y⟩. ⟨hal-03565962⟩

Share

Metrics

Record views

15